Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
Author(s) -
Emily M. Hsieh,
Regina M. Myers,
Bonnie Yates,
Colleen Annesley,
Samuel John,
Agne Taraseviciute,
Seth M. Steinberg,
Jennifer Sheppard,
Perry Chung,
Lee Chen,
Daniel W. Lee,
Amanda M. DiNofia,
Stephan A. Grupp,
Michael R. Verneris,
Theodore W. Laetsch,
Deepa Bhojwani,
Patrick A. Brown,
Michael A. Pulsipher,
Susan R. Rheingold,
Rebecca Gardner,
Lia Gore,
Nirali N. Shah,
Adam J. Lamble
Publication year - 2022
Publication title -
blood advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 39
eISSN - 2473-9537
pISSN - 2473-9529
DOI - 10.1182/bloodadvances.2022008093
Subject(s) - cumulative incidence , medicine , oncology , incidence (geometry) , cancer , disease , cd19 , pediatric cancer , childhood cancer , immune system , immunology , pediatrics , transplantation , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom